Barcelona, CATALONIA4 Active Studies

Myalgic Encephalomyelitis Clinical Trials in Barcelona, CATALONIA

Find 4 actively recruiting myalgic encephalomyelitis clinical trials in Barcelona, CATALONIA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
256
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in Barcelona

About Myalgic Encephalomyelitis Clinical Trials in Barcelona

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 4 myalgic encephalomyelitis clinical trials recruiting participants in Barcelona, CATALONIA. These studies are seeking a combined 256 participants. Research is being sponsored by AC Immune SA, Novartis Pharmaceuticals, Ultragenyx Pharmaceutical Inc and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Barcelona — FAQ

Are there myalgic encephalomyelitis clinical trials in Barcelona?

Yes, there are 4 myalgic encephalomyelitis clinical trials currently recruiting in Barcelona, CATALONIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Barcelona?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Barcelona research site will contact you about next steps.

Are clinical trials in Barcelona free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Barcelona studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 4 active trials in Barcelona are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated March 2, 2026 from ClinicalTrials.gov